BAVETTA, Maria Grazia
BAVETTA, Maria Grazia
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis
2013-01-01 DI MARCO, V.; Calvaruso, V.; Grimaudo, S.; Ferraro, D.; Bavetta, M.; Di Cristina, A.; Cabibbo, G.; Conte, E.; Craxi, A.
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
2016-01-01 Di Marco, V.; Calvaruso, V.; Ferraro, D.; Bavetta, M.; Cabibbo, G.; Conte, E.; Cammà, C.; Grimaudo, S.; Pipitone, R.; Simone, F.; Peralta, S.; Arini, A.; Craxì, A.
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance
2013-01-01 Calvaruso, V; Di Marco, V; Ferraro, D; Petta, S; Calì, A; Bavetta, MG; Conte, E; Almasio, PL
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals
2018-01-01 Calvaruso, V.; Ferraro, D.; Licata, A.; Bavetta, M.; Petta, S.; Bronte, F.; Colomba, G.; Craxi, A.; DI MARCO, V.
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma
2016-01-01 Bronte, F.; Bronte, G.; Fanale, D.; Caruso, S.; Bronte, E.; Bavetta, M.; Fiorentino, E.; Rolfo, C.; Bazan, V.; Marco, V.; Russo, A.
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis
2015-01-01 Calvaruso V, Di Marco V, Bavetta MG, Cabibi D, Conte E, Bronte F, Simone F, Burroughs AK, Craxì A.
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV
2012-01-01 Calvaruso, V.; Bavetta, M.; Ferraro, D.; Grimaudo, S.; Conte, E.; Pipitone, R.; Craxi, A.; DI MARCO, V.
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment
2015-01-01 Bronte, E.; Bronte, G.; Novo, G.; Bronte, F.; Bavetta, M.; Re, G.; Brancatelli, G.; Bazan, V.; Natoli, C.; Novo, S.; Russo, A.